KRM Ayurveda IPO Day 3: Live Subscription Status, Allotment Date

KRM Ayurveda IPO is in focus on Day 3 of bidding as the SME public issue closes on Friday, January 23, 2026. The IPO has been launched in a price band of ₹128 to ₹135 per share and aims to raise ₹77.49 crore through a fresh issue of 57.40 lakh equity shares. The issue does not include any offer for sale (OFS) component.

As per NSE SME data, the IPO was subscribed 3.22 times as of Day 2. The issue received bids for 1.35 crore shares against 41.98 lakh shares on offer, indicating healthy demand from investors. The final subscription numbers will be available after 10 am on the closing day.

The proceeds from the issue will be utilised for repayment of debt, construction and development of telemedicine operational facilities, strengthening human resources, procurement of CRM software and hardware infrastructure, meeting working capital requirements, and general corporate purposes.

According to the company’s red herring prospectus (RHP), KRM Ayurveda believes that listing on the stock exchange will enhance its corporate image, strengthen brand visibility, and create a public market for its equity shares in India.

KRM Ayurveda operates a network of hospitals and clinics across India and has also expanded its presence internationally through telemedicine consultations and product sales.

The basis of allotment for KRM Ayurveda IPO is expected to be finalised on Tuesday, January 27, 2026. Shares of the company are scheduled to be listed on the stock exchange on Thursday, January 29, 2026.

Investors who have applied for the IPO can check their allotment status online through the NSE website by selecting the Equity & SME IPO bid details option and entering their application number and PAN. The allotment status can also be checked on the registrar Skyline Financial Services’ website by providing PAN, DPID/Client ID, or application details.

As per market trackers and media reports, KRM Ayurveda’s unlisted shares are trading at around ₹151 in the grey market, indicating a grey market premium (GMP) of approximately 11.85% over the upper IPO price band of ₹135.

Disclaimer: Grey Market Premium (GMP) is unofficial and is not regulated or recommended by SEBI or stock exchanges. Investors should conduct their own research or consult financial experts before making any investment decisions.